Insider Transactions by ODINK DEBRA

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ANTHAnthera Pharmaceuticals IncODINK DEBRAChief Technology OfficerOct 12, 2015Sale$6.151,2057,4117,896Oct 13, 2015, 08:02 PM
ANTHAnthera Pharmaceuticals IncODINK DEBRAChief Technology OfficerMar 25, 2014Option Exercise$3.302,7839,1846,601Mar 27, 2014, 09:57 PM
ANTHAnthera Pharmaceuticals IncODINK DEBRAChief Technology OfficerJun 30, 2013Option Exercise$0.492,2481,10275,074Jul 02, 2013, 09:17 PM
ANTHAnthera Pharmaceuticals IncODINK DEBRAChief Technology OfficerJan 03, 2013Option Exercise$0.693,4092,35231,812Jan 07, 2013, 09:18 PM
ANTHAnthera Pharmaceuticals IncODINK DEBRAChief Technology OfficerJun 30, 2012Option Exercise$0.691,8381,26824,821Jul 03, 2012, 07:27 PM
ANTHAnthera Pharmaceuticals IncODINK DEBRAChief Technology OfficerMar 01, 2012Sale$6.572,00013,14026,659Mar 05, 2012, 04:01 PM
ANTHAnthera Pharmaceuticals IncODINK DEBRAChief Technology OfficerFeb 01, 2012Sale$7.672,00015,34021,241Feb 03, 2012, 04:01 PM
ANTHAnthera Pharmaceuticals IncODINK DEBRAChief Technology OfficerJan 10, 2012Sale$6.518005,20523,241Jan 12, 2012, 12:58 PM
ANTHAnthera Pharmaceuticals IncODINK DEBRAChief Technology OfficerJan 06, 2012Sale$6.501,2007,80024,441Jan 10, 2012, 02:27 PM
ANTHAnthera Pharmaceuticals IncODINK DEBRAVP, Pharmaceutical R&DJun 30, 2011Option Exercise$8.173,67029,98425,641Jul 05, 2011, 06:23 PM
ANTHAnthera Pharmaceuticals IncODINK DEBRAVP, Pharmaceutical R&DApr 13, 2011Option Exercise$1.513,3115,00029,311Apr 14, 2011, 08:36 PM
ANTHAnthera Pharmaceuticals IncODINK DEBRAVP, Pharmaceutical R&DSep 24, 2010Buy$4.201,0004,20026,000Sep 24, 2010, 09:22 PM